Application 208048

Type
ANDA
Sponsor
DR REDDYS LABS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DABIGATRAN ETEXILATE MESYLATEDABIGATRAN ETEXILATE MESYLATECAPSULE;ORALEQ 75MG BASENoNo
002DABIGATRAN ETEXILATE MESYLATEDABIGATRAN ETEXILATE MESYLATECAPSULE;ORALEQ 110MG BASENoNo
003DABIGATRAN ETEXILATE MESYLATEDABIGATRAN ETEXILATE MESYLATECAPSULE;ORALEQ 150MG BASENoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208048-001DABIGATRAN ETEXILATE MESYLATEDABIGATRAN ETEXILATE MESYLATEEQ 75MG BASECAPSULE / ORALAB2025-01-28
A208048-002DABIGATRAN ETEXILATE MESYLATEDABIGATRAN ETEXILATE MESYLATEEQ 110MG BASECAPSULE / ORALAB2025-01-28
A208048-003DABIGATRAN ETEXILATE MESYLATEDABIGATRAN ETEXILATE MESYLATEEQ 150MG BASECAPSULE / ORALAB2025-01-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A208048-001AB
A208048-002AB
A208048-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A208048-001DABIGATRAN ETEXILATE MESYLATEEQ 75MG BASECAPSULE / ORALAB2025-01-28a50c72e98297…
2026-08-01 22:54:322026-06A208048-002DABIGATRAN ETEXILATE MESYLATEEQ 110MG BASECAPSULE / ORALAB2025-01-28a50c72e98297…
2026-08-01 22:54:322026-06A208048-003DABIGATRAN ETEXILATE MESYLATEEQ 150MG BASECAPSULE / ORALAB2025-01-28a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A208048-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A208048-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A208048-003AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Dabigatran etexilateDABIGATRAN ETEXILATEDr.Reddys Laboratories Inca608e019-db9a-d6fb-cd0d-cecc1351a2b12025-07-24Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208048
application number: ANDA208048

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
65433ORIG2020-12-01